gene therapy R&D

Biotech Avrobio plans head-to-head Fabrazyme trial after FDA changes path to market
Fierce Biotech
Mon, 05/3/21 - 10:59 am
Avrobio
Fabry disease
gene therapy R&D
Sanofi
AVR-RD-01